News
16/9/2019
Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation
Download8/8/2019
Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing
Download4/7/2019
Ares Genetics is Granted Key European Patent on Genetic Resistance Testing
Download12/4/2019
Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019
Download18/2/2019
Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
Download8/1/2019
Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test
Download18/12/2018
Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance
Download4/9/2018
Ares Genetics Initiates Development of AI-Powered Infectious Disease Test
Download31/7/2018
Ares Genetics Launches ARES & CO Pharma Partnering Program
Download18/4/2018
Curetis: Novel Products and Study Data to be Presented at ECCMID 2018
Download6/3/2018
Ares Genetics wins incubator stay in Silicon Valley
Download5/2/2018
Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017
Download10/1/2018
Curetis and MGI Advance Strategic Partnership in NGS- Based Molecular Microbiology
Download12/9/2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
Download26/6/2017
"GEAR - Predicting Antibiotic Resistances with Genetic Data" Succeeds in Competition "Landmarks in the Land of Ideas"
Download6/4/2017
Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing
Download9/7/2016
Curetis Acquires Patents and Rights to Genetic Antibiotic Resistance and Susceptibility (GEAR) Database and Know- How from Siemens
Download
